
Healthcare/Biotech2025-12-31 기준
Julian Baker
Baker Brothers Advisors LP
베이커 브라더스의 공동설립자. 바이오텍 전문 헤지펀드로 $17B을 운용하며, 신약 개발 기업에 대한 장기 집중 투자로 유명하다.
$17.01BAUM
76Holdings
2025-12-31 요약
5개 종목 신규 매수 (TERN, JBIO, BCRX 등) · 6개 종목 추가 매수 (CTNM, TECX, CRNX 등) · 6개 비중 축소 · 최대 보유: INCY 17.8%
Portfolio Heatmap
크기 = 포트폴리오 비중 · 초록 = 보유량 늘림 · 빨강 = 보유량 줄임This Quarter's Trades
2025-12-31 기준New Buy5건
Holdings
76개 종목| # | Stock ⇅ | Weight ↓ | Shares | Value | Change ⇅ | Trend |
|---|---|---|---|---|---|---|
| 1 | CELCCelcuity Inc. | 10.33% | 7,915,792 | $789.52M | +0.00% | No Change |
| 2 | RVMDRevolution Medicines, Inc. | 9.86% | 9,455,357 | $753.12M | +0.00% | No Change |
| 3 | KYMRKymera Therapeutics, Inc. | 8.82% | 8,657,242 | $673.62M | +30.16% | Added |
| 4 | SMMTSummit Therapeutics Inc. | 8.33% | 36,391,063 | $636.48M | +7.91% | Added |
| 5 | RYTMRhythm Pharmaceuticals, Inc. | 7.85% | 5,604,483 | $599.90M | +0.00% | No Change |
| 6 | KODKodiak Sciences Inc. | 7.29% | 19,919,186 | $556.94M | +15.07% | Added |
| 7 | PRAXPraxis Precision Medicines, Inc. | 4.35% | 1,126,488 | $332.02M | +63.38% | Added |
| 8 | ALKSAlkermes plc | 3.67% | 10,012,267 | $280.14M | +23.74% | Added |
| 9 | GRALGRAIL, Inc. | 2.34% | 2,085,333 | $178.48M | +27.92% | Added |
| 10 | EWTXEdgewise Therapeutics, Inc. | 2.14% | 6,575,940 | $163.18M | -9.99% | Partial Sell |
FAQ
Need Deeper Analysis?
Track Julian Baker's portfolio changes in real-time,
compare gurus head-to-head, and analyze performance vs S&P 500 with Premium.